MX2010001572A - Marcador predictivo para tratamiento con el inhibidor del receptor del factor de crecimiento epidermico. - Google Patents
Marcador predictivo para tratamiento con el inhibidor del receptor del factor de crecimiento epidermico.Info
- Publication number
- MX2010001572A MX2010001572A MX2010001572A MX2010001572A MX2010001572A MX 2010001572 A MX2010001572 A MX 2010001572A MX 2010001572 A MX2010001572 A MX 2010001572A MX 2010001572 A MX2010001572 A MX 2010001572A MX 2010001572 A MX2010001572 A MX 2010001572A
- Authority
- MX
- Mexico
- Prior art keywords
- treamtent
- egfr inhibitor
- predictive marker
- predictive
- marker
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención proporciona un biomarcador que es predictivo para el beneficio clínico al tratamiento con el inhibidor de EGFR en pacientes con cáncer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07114305 | 2007-08-14 | ||
PCT/EP2008/006518 WO2009021679A1 (en) | 2007-08-14 | 2008-08-07 | Predictive marker for egfr inhibitor treamtent |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010001572A true MX2010001572A (es) | 2010-03-15 |
Family
ID=39789783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010001572A MX2010001572A (es) | 2007-08-14 | 2008-08-07 | Marcador predictivo para tratamiento con el inhibidor del receptor del factor de crecimiento epidermico. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2176429A1 (es) |
JP (1) | JP2010535520A (es) |
KR (1) | KR20100037633A (es) |
CN (1) | CN101802221A (es) |
AU (1) | AU2008286412A1 (es) |
BR (1) | BRPI0815372A2 (es) |
CA (1) | CA2695318A1 (es) |
MX (1) | MX2010001572A (es) |
WO (1) | WO2009021679A1 (es) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5646249A (en) * | 1994-02-28 | 1997-07-08 | The United States Of America As Represented By The Department Of Health And Human Services | Isolation and characterization of a novel chaperone protein |
AU2004248140A1 (en) * | 2003-05-30 | 2004-12-23 | Cedars-Sinai Medical Center | Gene expression markers for response to EGFR inhibitor drugs |
KR101126560B1 (ko) * | 2003-05-30 | 2012-04-05 | 도꾜 다이가꾸 | 약제 반응 예측 방법 |
-
2008
- 2008-08-07 AU AU2008286412A patent/AU2008286412A1/en not_active Abandoned
- 2008-08-07 JP JP2010520467A patent/JP2010535520A/ja active Pending
- 2008-08-07 WO PCT/EP2008/006518 patent/WO2009021679A1/en active Application Filing
- 2008-08-07 CA CA2695318A patent/CA2695318A1/en not_active Abandoned
- 2008-08-07 MX MX2010001572A patent/MX2010001572A/es not_active Application Discontinuation
- 2008-08-07 KR KR1020107003252A patent/KR20100037633A/ko not_active Application Discontinuation
- 2008-08-07 EP EP08785424A patent/EP2176429A1/en not_active Ceased
- 2008-08-07 BR BRPI0815372A patent/BRPI0815372A2/pt not_active IP Right Cessation
- 2008-08-07 CN CN200880102973A patent/CN101802221A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2009021679A1 (en) | 2009-02-19 |
AU2008286412A1 (en) | 2009-02-19 |
CA2695318A1 (en) | 2009-02-19 |
KR20100037633A (ko) | 2010-04-09 |
CN101802221A (zh) | 2010-08-11 |
BRPI0815372A2 (pt) | 2019-09-24 |
EP2176429A1 (en) | 2010-04-21 |
JP2010535520A (ja) | 2010-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010017515A3 (en) | Breast cancer specific markers and methods of use | |
WO2010146059A3 (en) | Biomarkers for igf-1r inhibitor therapy | |
ZA200702973B (en) | Disubstituted pyrazolobenzodiazepines useful as inhibitors for CDK2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer | |
MX2013002084A (es) | Biomarcadores y metodos de tratamiento. | |
IN2012DN03012A (es) | ||
EA201171367A1 (ru) | Винилиндазолильные соединения | |
WO2008008430A3 (en) | Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases | |
WO2008031551A3 (en) | Non-neuroendocrine cancer therapy | |
HK1145342A1 (en) | Prognosis prediction for melanoma cancer | |
MX2011011431A (es) | Composicion para el tratamiento de cancer de prostata. | |
MX2010001571A (es) | Marcador predictivo para tratamiento con el inhibidor del receptor del factor de crecimiento epidermico. | |
GB2480980A (en) | Methods for predicting cancer response to EGFR inhibitors | |
WO2010015538A3 (en) | Predictive marker for egfr inhibitor treatment | |
MX343803B (es) | Complejo de ipp como marcador para tratamiento de erlotinib. | |
MX2010001573A (es) | Marcador predictivo para tratamiento con el inhibidor del receptor del factor de crecimiento epidermico. | |
MX2010001577A (es) | Marcador predictivo para tratamiento con el inhibidor del receptor del factor de crecimiento epidermico. | |
MX2010001583A (es) | Maracdor predictivo para tratamiento con el inhibidor del receptor del factor de crecimiento epidermico. | |
MX2010001570A (es) | Marcador predictivo para tratamiento con el inhibidor del receptor del factor de crecimiento epidermico. | |
MX2010001578A (es) | Marcador predictivo para tratamiento con el inhibidor del receptor del factor de crecimiento epidermico. | |
MX2010001572A (es) | Marcador predictivo para tratamiento con el inhibidor del receptor del factor de crecimiento epidermico. | |
MX2010001582A (es) | Marcador predictivo para tratamiento con el inhibidor del receptor del factor de crecimiento epidermico. | |
TN2009000448A1 (en) | Use of hdac inhibitors for the treatment of bone destruction | |
MX2010001579A (es) | Maracador predictivo para tratamiento con el inhibidor del receptor del factor de crecimiento epidermico. | |
MX2010001580A (es) | Marcador predictivo para tratamiento con el inhibidor del receptor del factor de crecimiento epidermico. | |
EP2330908A4 (en) | FLUORESCENT CDK INHIBITORS FOR CANCER TREATMENT |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |